EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet

Swati Saxena, Sachin Kumar Jain

International Journal of Drug Delivery Technology · 30.07.2026 · 16 (71s)

DOI: 10.25258/ijddt.16.71s.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.07.2026. Verfasst von Swati Saxena und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Saxena, S., & Jain, S. K. (2026). Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet. International Journal of Drug Delivery Technology, 16(71s). https://doi.org/10.25258/ijddt.16.71s.1

Vancouver

Saxena S, Jain SK. Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet. International Journal of Drug Delivery Technology. 2026;16(71s). doi:10.25258/ijddt.16.71s.1

BibTeX
@article{Saxena2026,
  author = {Saxena, Swati and Jain, Sachin Kumar},
  title = {Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Dapagliflozin, Metformin Hydrochloride, and Vildagliptin in a Fixed-Dose Combination Tablet},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {71s},
  doi = {10.25258/ijddt.16.71s.1}
}
Kostenlos starten →